Sameh Elfangary leads PHRMAG's new Executive Committee for 2025-2027
Portfolio - People | Feb 11, 2025 | Zawya
The Pharmaceutical Research and Manufacturers Association Gulf (PHRMAG) has announced its new Executive Committee (EC) for 2025-2027, appointing Sameh Elfangary as Chairman. PHRMAG, founded in 2005, represents 29 leading global biopharmaceutical firms in the Gulf region committed to innovation in healthcare and patient care. The EC includes executives from major global pharmaceutical companies such as AstraZeneca, MSD, Merck Serono, Biogen, AbbVie, Abbott, and Johnson & Johnson, tasked with navigating the rapidly transforming healthcare landscape and ensuring sustainable access to life-saving medicines. Under the outgoing committee, PHRMAG enhanced industry collaboration with entities such as the Emirates Drug Establishment and advanced key healthcare initiatives. PHRMAG's Working Groups notably fostered ethical practices, championed intellectual property dialogues, and collaborated on pivotal events, leaving a legacy of progress. The new leadership looks to carry on the mission of fostering innovation and equitable patient access across the Gulf.
Sectors
- Biopharmaceutical
- Healthcare
Geography
- Gulf Region – The focus of PHRMAG and its initiatives is on the Gulf region, where it represents 29 global biopharmaceutical companies.
- United Arab Emirates – The announcement of PHRMAG's new Executive Committee and key initiatives are closely linked to healthcare advancements within the UAE.
Industry
- Biopharmaceutical – The article pertains to the biopharmaceutical industry, focusing on PHRMAG, an association of leading biopharmaceutical companies in the Gulf dedicated to innovation and patient care.
- Healthcare – PHRMAG collaborates with healthcare authorities and stakeholders to enhance healthcare initiatives, positioning the Gulf as a leader in pharmaceutical innovation.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| PHRMAG | Announcing Organization | Association | The Pharmaceutical Research and Manufacturers Association Gulf represents 29 leading global biopharmaceutical research companies in the Gulf region. |
| Sameh Elfangary | Chairman | Person | Recently appointed as Chairman of PHRMAG's Executive Committee for 2025-2027, he is also the Cluster President at AstraZeneca GCC & Pakistan. |
| AstraZeneca | Member Company | Company | A leading biopharmaceutical company represented by Sameh Elfangary in the PHRMAG Executive Committee. |
| MSD | Member Company | Company | Another key biopharmaceutical company with Ashraf Mallak as Vice Chairman and Managing Director GCC in the PHRMAG EC. |
| Merck Serono | Member Company | Company | Represented by Ahmed Abu El Fadl as an EC member, it is a vital part of the PHRMAG. |
| Biogen | Member Company | Company | Diederik Kok represents Biogen in the PHRMAG Executive Committee, overseeing GCC operations. |
| AbbVie Biopharmaceuticals GmbH | Member Company | Company | Elhussein Abdellatif is the General Manager Gulf Levant at AbbVie and a member of the PHRMAG EC. |
| Abbott | Member Company | Company | Mazen Bachir, former PHRMAG Chairman, is now a regional director covering Gulf, Levant, and Emerging Markets. |
| Johnson & Johnson | Member Company | Company | Pedro Matos Rosa represents J&J in the EC as General Manager at Johnson & Johnson Innovative Medicines Gulf. |
| Emirates Drug Establishment | Collaborating Organization | Government | Worked with PHRMAG to advance sustainable healthcare initiatives. |
| Department of Health Abu Dhabi | Collaborating Organization | Government | Engaged with PHRMAG for healthcare advancements in the Abu Dhabi region. |
| U.S. Chamber of Commerce | Collaborator | Organization | Partnered with PHRMAG for a roundtable on intellectual property in the GCC. |
| GCC Patent Office | Collaborator | Government | Part of the roundtable hosted to discuss intellectual property frameworks in the GCC facilitated by PHRMAG. |